Spots Global Cancer Trial Database for systemic sclerosis
Every month we try and update this database with for systemic sclerosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3) | NCT04040322 | Raynaud's Pheno... | Placebo IV infu... Iloprost Inject... | 18 Years - | Eicos Sciences, Inc. | |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | NCT03941184 | SCAD Addison Disease Ankylosing Spon... Antiphospholipi... Celiac Disease Crohn Disease Dermatomyositis Polymyositis Guillain-Barre ... Hepatitis, Auto... Graves Disease Hashimoto Thyro... Multiple Sclero... Myasthenia Grav... Pernicious Anem... Polymyalgia Rhe... Primary Biliary... Psoriasis Rheumatoid Arth... Systemic Sclero... Sjögren Syndrom... Systemic Lupus ... Takayasu Arteri... Type 1 Diabetes... Ulcerative Coli... Uveitis Vasculitis Vitiligo Raynaud | 18 Years - 110 Years | Mayo Clinic | ||
| Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2) | NCT03867097 | Raynaud Phenome... | Placebo IV infu... Iloprost Inject... | 18 Years - | Eicos Sciences, Inc. | |
| Sonographic and Laboratory Evaluation of the Thyroid Gland in Patients With Systemic Sclerosis | NCT01270425 | Systemic Sclero... Hashimoto Thyro... Thyroid Nodules | 18 Years - | Meir Medical Center | ||
| Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis | NCT03717961 | Raynaud Phenome... | BOTOX® solution Placebo group | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis | NCT02260557 | Raynaud's Pheno... | Selexipag Placebo | 18 Years - | Actelion | |
| Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3) | NCT04040322 | Raynaud's Pheno... | Placebo IV infu... Iloprost Inject... | 18 Years - | Eicos Sciences, Inc. | |
| Lab Study of MQX-503 in Treatment of Raynaud's | NCT00253331 | Raynaud Disease Raynaud Disease... Raynaud Seconda... | topical organog... | 18 Years - 80 Years | MediQuest Therapeutics | |
| A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis | NCT04915950 | Raynaud's Pheno... | Temanogrel Placebo | 18 Years - 75 Years | Pfizer | |
| Sonographic and Laboratory Evaluation of the Thyroid Gland in Patients With Systemic Sclerosis | NCT01270425 | Systemic Sclero... Hashimoto Thyro... Thyroid Nodules | 18 Years - | Meir Medical Center | ||
| Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3) | NCT04040322 | Raynaud's Pheno... | Placebo IV infu... Iloprost Inject... | 18 Years - | Eicos Sciences, Inc. | |
| Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis | NCT03717961 | Raynaud Phenome... | BOTOX® solution Placebo group | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis | NCT02260557 | Raynaud's Pheno... | Selexipag Placebo | 18 Years - | Actelion |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
